The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 11, 2026 | Green Andrew M | SVP, Regulatory and Quality | Option exercise(M) | 14K | $18.44 | $258K |
| Jun 11, 2026 | Green Andrew M | SVP, Regulatory and Quality | Sell(S) | 14K | $20.71 | $290K |
| Jun 11, 2026 | Green Andrew M | SVP, Regulatory and Quality | Option exercise(M) | 30K | $11.03 | $331K |
| Jun 11, 2026 | Green Andrew M | SVP, Regulatory and Quality | Sell(S) | 30K | $20.69 | $621K |
| Jun 11, 2026 | Green Andrew M | SVP, Regulatory and Quality | Option exercise(M) | 14K | — | $0 |
| Jun 11, 2026 | Green Andrew M | SVP, Regulatory and Quality | Option exercise(M) | 30K | — | $0 |
| Jun 2, 2026 | Semedo Anthony B. | Director | Other(J) | 6K | — | $0 |
| Jun 2, 2026 | Semedo Anthony B. | Director | Other(J) | 6K | — | $0 |
| May 18, 2026 | Bevevino Daniel J | Director | Grant(A) | 8K | — | $0 |
| May 18, 2026 | Bullock James | Director | Grant(A) | 8K | — | $0 |
| May 18, 2026 | Burbank Jeffrey H | Director | Grant(A) | 8K | — | $0 |
| May 18, 2026 | Hoff Elizabeth A | Director | Grant(A) | 8K | — | $0 |
| May 18, 2026 | Salveson Jon W | Director | Grant(A) | 8K | — | $0 |
| May 18, 2026 | Semedo Anthony B. | Director | Grant(A) | 8K | — | $0 |
| May 18, 2026 | Ackerman Thomas F | Director | Grant(A) | 8K | — | $0 |
| May 18, 2026 | Borgstrom Marna P | Director | Grant(A) | 8K | — | $0 |
| Mar 4, 2026 | Holloway Jean F | SVP, General Counsel | Sell(S) | 9K | $38.00 | $341K |
| Mar 3, 2026 | Mackin James P | President & CEO | Sell(S) | 18K | $37.78 | $676K |
| Mar 3, 2026 | Berry Lance A | EVP, COO, CFO & Treasurer | Sell(S) | 6K | $37.78 | $239K |
| Mar 3, 2026 | Davis John E | Chief Commercial Officer | Sell(S) | 5K | $37.78 | $173K |
| Mar 3, 2026 | Stanton Marshall S. | SVP, Clinical & MD Affair | Sell(S) | 2K | $37.78 | $81K |
| Mar 3, 2026 | Holloway Jean F | SVP, General Counsel | Sell(S) | 4K | $37.78 | $145K |
| Mar 3, 2026 | Horton Amy | VP, Chief Accounting Officer | Sell(S) | 901 | $37.78 | $34K |
| Mar 2, 2026 | Davis John E | Chief Commercial Officer | Sell(S) | 3K | $38.02 | $106K |
| Mar 2, 2026 | Berry Lance A | EVP, COO, CFO & Treasurer | Sell(S) | 5K | $38.02 | $197K |
| Mar 2, 2026 | Holloway Jean F | SVP, General Counsel | Sell(S) | 2K | $38.02 | $83K |
| Mar 2, 2026 | Mackin James P | President & CEO | Sell(S) | 15K | $38.02 | $567K |
| Mar 2, 2026 | Stanton Marshall S. | SVP, Clinical & MD Affair | Sell(S) | 2K | $38.02 | $58K |
| Mar 2, 2026 | Horton Amy | VP, Chief Accounting Officer | Sell(S) | 641 | $38.02 | $24K |
| Mar 2, 2026 | Mackin James P | President & CEO | Grant(A) | 117K | — | $0 |
| Mar 2, 2026 | Berry Lance A | EVP, COO, CFO & Treasurer | Grant(A) | 41K | — | $0 |
| Mar 2, 2026 | Davis John E | Chief Commercial Officer | Grant(A) | 29K | — | $0 |
| Mar 2, 2026 | Stanton Marshall S. | SVP, Clinical & MD Affair | Grant(A) | 22K | — | $0 |
| Mar 2, 2026 | Holloway Jean F | SVP, General Counsel | Grant(A) | 28K | — | $0 |
| Mar 2, 2026 | Horton Amy | VP, Chief Accounting Officer | Grant(A) | 7K | — | $0 |
| Feb 24, 2026 | Davis John E | Chief Commercial Officer | Sell(S) | 2K | $35.69 | $74K |
| Feb 24, 2026 | Davis John E | Chief Commercial Officer | Grant(A) | 20K | — | $0 |
| Feb 24, 2026 | Berry Lance A | EVP, COO, CFO & Treasurer | Sell(S) | 4K | $35.69 | $160K |
| Feb 24, 2026 | Berry Lance A | EVP, COO, CFO & Treasurer | Grant(A) | 37K | — | $0 |
| Feb 24, 2026 | Mackin James P | President & CEO | Grant(A) | 97K | — | $0 |
| Feb 24, 2026 | Mackin James P | President & CEO | Sell(S) | 14K | $35.69 | $497K |
| Feb 24, 2026 | Holloway Jean F | SVP, General Counsel | Grant(A) | 20K | — | $0 |
| Feb 24, 2026 | Holloway Jean F | SVP, General Counsel | Sell(S) | 2K | $35.69 | $60K |
| Feb 24, 2026 | Stanton Marshall S. | SVP, Clinical & MD Affair | Sell(S) | 1K | $35.69 | $45K |
| Feb 24, 2026 | Horton Amy | VP, Chief Accounting Officer | Sell(S) | 830 | $35.69 | $30K |
| Feb 24, 2026 | Horton Amy | VP, Chief Accounting Officer | Grant(A) | 6K | — | $0 |
| Feb 23, 2026 | Davis John E | Chief Commercial Officer | Sell(S) | 4K | $37.59 | $142K |
| Feb 23, 2026 | Berry Lance A | EVP, COO, CFO & Treasurer | Sell(S) | 5K | $37.59 | $187K |
| Feb 23, 2026 | Mackin James P | President & CEO | Sell(S) | 21K | $37.59 | $788K |
| Feb 23, 2026 | Holloway Jean F | SVP, General Counsel | Sell(S) | 3K | $37.59 | $116K |
| Feb 23, 2026 | Stanton Marshall S. | SVP, Clinical & MD Affair | Sell(S) | 2K | $37.59 | $91K |
| Feb 23, 2026 | Horton Amy | VP, Chief Accounting Officer | Sell(S) | 2K | $37.59 | $65K |
| Dec 15, 2025 | Davis John E | Chief Commercial Officer | Sell(S) | 5K | $45.11 | $226K |
| Dec 8, 2025 | Horton Amy | VP, Chief Accounting Officer | Sell(S) | 5K | $44.42 | $203K |
| Dec 3, 2025 | Holloway Jean F | SVP, General Counsel | Sell(S) | 2K | $45.30 | $93K |
| Dec 3, 2025 | Holloway Jean F | SVP, General Counsel | Sell(S) | 5K | $45.30 | $239K |
| Dec 3, 2025 | Mackin James P | President & CEO | Sell(S) | 31K | $45.46 | $1.4M |
| Dec 3, 2025 | Mackin James P | President & CEO | Option exercise(M) | 31K | $29.62 | $916K |
| Dec 3, 2025 | Mackin James P | President & CEO | Option exercise(M) | 31K | — | $0 |
| Dec 2, 2025 | Mackin James P | President & CEO | Sell(S) | 31K | $45.56 | $1.4M |
| Dec 2, 2025 | Mackin James P | President & CEO | Option exercise(M) | 31K | $29.62 | $916K |
| Dec 2, 2025 | Mackin James P | President & CEO | Option exercise(M) | 31K | — | $0 |
| Dec 1, 2025 | Horton Amy | VP, Chief Accounting Officer | Gift(G) | 750 | — | $0 |
| Nov 21, 2025 | Stanton Marshall S. | SVP, Clinical & MD Affair | Sell(S) | 19K | $44.91 | $840K |
| Nov 21, 2025 | Stanton Marshall S. | SVP, Clinical & MD Affair | Sell(S) | 8K | $45.35 | $380K |
| Nov 21, 2025 | Stanton Marshall S. | SVP, Clinical & MD Affair | Option exercise(M) | 20K | $18.44 | $374K |
| Nov 21, 2025 | Stanton Marshall S. | SVP, Clinical & MD Affair | Sell(S) | 15K | $44.92 | $655K |
| Nov 21, 2025 | Stanton Marshall S. | SVP, Clinical & MD Affair | Sell(S) | 6K | $45.35 | $259K |
| Nov 21, 2025 | Stanton Marshall S. | SVP, Clinical & MD Affair | Option exercise(M) | 27K | $11.03 | $299K |
| Nov 21, 2025 | Stanton Marshall S. | SVP, Clinical & MD Affair | Option exercise(M) | 20K | — | $0 |
| Nov 21, 2025 | Stanton Marshall S. | SVP, Clinical & MD Affair | Option exercise(M) | 27K | — | $0 |
| Nov 20, 2025 | Stanton Marshall S. | SVP, Clinical & MD Affair | Option exercise(M) | 1K | $11.03 | $15K |
| Nov 20, 2025 | Stanton Marshall S. | SVP, Clinical & MD Affair | Sell(S) | 1K | $44.28 | $60K |
| Nov 20, 2025 | Stanton Marshall S. | SVP, Clinical & MD Affair | Sell(S) | 2K | $44.32 | $90K |
| Nov 20, 2025 | Stanton Marshall S. | SVP, Clinical & MD Affair | Option exercise(M) | 2K | $18.44 | $37K |
| Nov 20, 2025 | Stanton Marshall S. | SVP, Clinical & MD Affair | Sell(S) | 12K | $44.14 | $525K |
| Nov 20, 2025 | Stanton Marshall S. | SVP, Clinical & MD Affair | Option exercise(M) | 1K | — | $0 |
| Nov 20, 2025 | Stanton Marshall S. | SVP, Clinical & MD Affair | Option exercise(M) | 2K | — | $0 |
| Nov 18, 2025 | Hoff Elizabeth A | Director | Sell(S) | 4K | $45.10 | $189K |
| Nov 17, 2025 | Horton Amy | VP, Chief Accounting Officer | Sell(S) | 6K | $45.73 | $274K |
| Nov 17, 2025 | Davis John E | Chief Commercial Officer | Sell(S) | 6K | $45.17 | $289K |
| Nov 17, 2025 | Davis John E | Chief Commercial Officer | Option exercise(M) | 6K | $29.62 | $189K |
| Nov 17, 2025 | Davis John E | Chief Commercial Officer | Option exercise(M) | 6K | — | $0 |
| Nov 17, 2025 | Holloway Jean F | SVP, General Counsel | Option exercise(M) | 6K | $29.62 | $189K |
| Nov 17, 2025 | Holloway Jean F | SVP, General Counsel | Sell(S) | 6K | $45.17 | $289K |
| Nov 17, 2025 | Holloway Jean F | SVP, General Counsel | Option exercise(M) | 6K | — | $0 |
| Nov 14, 2025 | Davis John E | Chief Commercial Officer | Sell(S) | 6K | $44.67 | $286K |
| Nov 14, 2025 | Davis John E | Chief Commercial Officer | Option exercise(M) | 6K | $29.62 | $189K |
| Nov 14, 2025 | Davis John E | Chief Commercial Officer | Option exercise(M) | 6K | — | $0 |
| Nov 14, 2025 | Holloway Jean F | SVP, General Counsel | Option exercise(M) | 6K | $29.62 | $189K |
| Nov 14, 2025 | Holloway Jean F | SVP, General Counsel | Sell(S) | 6K | $45.00 | $288K |
| Nov 14, 2025 | Holloway Jean F | SVP, General Counsel | Option exercise(M) | 6K | — | $0 |
| Nov 13, 2025 | Stanton Marshall S. | SVP, Clinical & MD Affair | Sell(S) | 5K | $45.86 | $229K |
| Nov 13, 2025 | Holloway Jean F | SVP, General Counsel | Sell(S) | 6K | $45.86 | $264K |
| Nov 13, 2025 | Mackin James P | President & CEO | Sell(S) | 34K | $45.86 | $1.6M |
| Nov 13, 2025 | Davis John E | Chief Commercial Officer | Sell(S) | 7K | $45.86 | $301K |
| Nov 13, 2025 | Horton Amy | VP, Chief Accounting Officer | Sell(S) | 3K | $45.86 | $160K |
| Nov 11, 2025 | Holloway Jean F | SVP, General Counsel | Sell(S) | 10K | $46.18 | $462K |
| Nov 11, 2025 | Holloway Jean F | SVP, General Counsel | Option exercise(M) | 10K | $11.03 | $110K |
| Nov 11, 2025 | Holloway Jean F | SVP, General Counsel | Option exercise(M) | 10K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-01-04 → 2026-07-21. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).